相似文献
1
T-cell epitope finding on EPHA2 for further glioma vaccine development: An immunomics study.
J Pediatr Neurosci. 2011 Jan;6(1):2-3. doi: 10.4103/1817-1745.84398.
2
A novel vaccine containing EphA2 epitope and LIGHT plasmid induces robust cellular immunity against glioma U251 cells.
Cell Immunol. 2011;272(1):102-6. doi: 10.1016/j.cellimm.2011.08.011. Epub 2011 Aug 31.
3
Finding a T-cell epitope for a melanoma vaccine by an immunomics technique.
Asian Pac J Cancer Prev. 2006 Oct-Dec;7(4):659-60.
4
A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach.
Front Immunol. 2021 Feb 26;12:598778. doi: 10.3389/fimmu.2021.598778. eCollection 2021.
5
Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma.
Cancer Res. 2003 Aug 1;63(15):4481-9.
6
EphA2 as a glioma-associated antigen: a novel target for glioma vaccines.
Neoplasia. 2005 Aug;7(8):717-22. doi: 10.1593/neo.05277.
7
Immunoinformatics Approach for the Identification and Characterization of T Cell and B Cell Epitopes towards the Peptide-Based Vaccine against SARS-CoV-2.
Arch Med Res. 2021 May;52(4):362-370. doi: 10.1016/j.arcmed.2021.01.004. Epub 2021 Jan 29.
8
An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice.
Hum Vaccin Immunother. 2017 Dec 2;13(12):2824-2836. doi: 10.1080/21645515.2017.1329788. Epub 2017 Jun 2.
9
Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach.
Infect Genet Evol. 2017 Dec;56:75-91. doi: 10.1016/j.meegid.2017.10.022. Epub 2017 Nov 1.
10
Development a multi-epitope driven subunit vaccine for immune response reinforcement against Serogroup B of Neisseria meningitidis using comprehensive immunoinformatics approaches.
Infect Genet Evol. 2019 Nov;75:103992. doi: 10.1016/j.meegid.2019.103992. Epub 2019 Aug 5.
本文引用的文献
1
[Glioblastoma treatment in 2010].
Rev Med Brux. 2009 Sep-Oct;30(5):496-505.
2
Monitoring immune responses after glioma vaccine immunotherapy.
Neurosurg Clin N Am. 2010 Jan;21(1):195-9. doi: 10.1016/j.nec.2009.09.004.
3
Clinical applications of a peptide-based vaccine for glioblastoma.
Neurosurg Clin N Am. 2010 Jan;21(1):95-109. doi: 10.1016/j.nec.2009.09.001.
4
Heat-shock protein vaccines as active immunotherapy against human gliomas.
Expert Rev Anticancer Ther. 2009 Nov;9(11):1577-82. doi: 10.1586/era.09.104.
5
Vaccine therapy with dendritic cells transfected with Il13ra2 mRNA for glioma in mice.
J Neurosurg. 2010 Aug;113(2):270-9. doi: 10.3171/2009.9.JNS09708.
6
Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccination.
J Immunol Methods. 2010 Jan 31;352(1-2):169-73. doi: 10.1016/j.jim.2009.10.007. Epub 2009 Oct 27.
7
Systemic inhibition of transforming growth factor-beta in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccines.
Clin Cancer Res. 2009 Nov 1;15(21):6551-9. doi: 10.1158/1078-0432.CCR-09-1067. Epub 2009 Oct 27.
8
An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme.
Mol Cancer Ther. 2009 Oct;8(10):2773-9. doi: 10.1158/1535-7163.MCT-09-0124.
9
Predicted epitopes of malarial merozoite surface protein 1 by bioinformatics method: a clue for further vaccine development.
J Microbiol Immunol Infect. 2009 Feb;42(1):19-21.
10
Dendritic-cell- and peptide-based vaccination strategies for glioma.
Neurosurg Rev. 2009 Jul;32(3):265-73; discussion 273. doi: 10.1007/s10143-009-0189-1. Epub 2009 Feb 13.
Zotero 插件